Zuclopenthixol



Indications and Reactions:

Role Indications Reactions
Secondary
Agitation 20.0%
Product Used For Unknown Indication 13.5%
Acute Psychosis 12.3%
Bipolar Disorder 9.4%
Hostility 7.7%
Prophylaxis 6.2%
Foetal Exposure During Pregnancy 4.8%
Schizoaffective Disorder 4.8%
Schizophrenia 3.3%
Psychotic Disorder 2.4%
Schizophrenia, Paranoid Type 2.2%
Schizophreniform Disorder 1.9%
Catatonia 1.7%
Drug Use For Unknown Indication 1.7%
Ill-defined Disorder 1.7%
Aggression 1.5%
Psychomotor Hyperactivity 1.5%
Schizoid Personality Disorder 1.2%
Hiv Infection 1.0%
Mental Disorder 1.0%
Weight Increased 17.1%
Neutropenia 11.4%
Syncope 11.4%
Death 5.7%
Drug Rash With Eosinophilia And Systemic Symptoms 5.7%
Neuroleptic Malignant Syndrome 4.3%
Overdose 4.3%
Pulmonary Embolism 4.3%
Waxy Flexibility 4.3%
Gestational Diabetes 2.9%
Head Titubation 2.9%
Hepatic Enzyme Increased 2.9%
Hypothermia 2.9%
Respiratory Distress 2.9%
Restlessness 2.9%
Stridor 2.9%
Sudden Death 2.9%
Urinary Retention 2.9%
Venous Thrombosis 2.9%
Viith Nerve Paralysis 2.9%
Concomitant
Schizophrenia 27.8%
Drug Use For Unknown Indication 13.0%
Psychotic Disorder 11.8%
Agitation 9.2%
Bipolar Disorder 7.7%
Anxiety 4.4%
Schizoaffective Disorder 4.4%
Schizophrenia, Paranoid Type 3.0%
Back Pain 2.7%
Mania 2.7%
Extrapyramidal Disorder 2.1%
Product Used For Unknown Indication 2.1%
Schizoid Personality Disorder 2.1%
Depression 1.2%
Overdose 1.2%
Pain 1.2%
Abnormal Behaviour 0.9%
Diabetes Mellitus 0.9%
Hiv Infection 0.9%
Hypomania 0.9%
White Blood Cell Count Decreased 15.2%
Weight Increased 10.1%
Suicidal Ideation 8.9%
Treatment Noncompliance 8.9%
Myocarditis 6.3%
Overdose 6.3%
Psychotic Disorder 5.1%
Schizophrenia 5.1%
Haemoglobin Decreased 3.8%
Memory Impairment 3.8%
Pulmonary Embolism 3.8%
Arrhythmia 2.5%
Cerebral Haemorrhage 2.5%
Differential White Blood Cell Count Abnormal 2.5%
Dizziness 2.5%
Hypotension 2.5%
Pericarditis 2.5%
Pregnancy 2.5%
Schizoaffective Disorder 2.5%
Snoring 2.5%
Interacting
Depression 44.4%
Overdose 44.4%
Major Depression 11.1%
Parkinsonism 57.1%
Dystonia 28.6%
Drug Interaction 14.3%